Mutations disrupting presynapticprotein TBC1D24 are associated with a variable neurological phenotype, including DOORS syndrome, myoclonic epilepsy, early-infantile epileptic encephalopathy, and non-syndromic hearing loss. Here, TBC1D24 is linked to genetic developmental and epileptic encephalopathy.